Miist Therapeutics Secures $7 in Seed Funding
Miist Therapeutics, a physics-based developer of inhaled medicines, announced $7M in seed funding from investors including Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First, and … Read more…